9 assets in Nicotine Dependence

Therapeutic assets addressing Nicotine Dependence, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Nicotine Nicotine Dependence	Brown University	P4	A (83)
Varenicline Nicotine Dependence	University of California, San Diego	P4	A (81)
Naltrexone Nicotine Dependence	Yale University	P4	BBB (72)
Semaglutide Nicotine Dependence	University of Oklahoma	P4	BBB (72)
Cefadroxil Anhydrous Nicotine Dependence	Mayo Clinic	P4	BB (65)
Cephalexin Nicotine Dependence	Mayo Clinic	P4	BB (65)
Doxycycline Nicotine Dependence	Mayo Clinic	P4	B (62)
Nivolumab Nicotine Dependence	University of Colorado, Denver	P2	CCC (53)